Publisher
Springer Science and Business Media LLC
Reference48 articles.
1. Peeters F, Dekervel J. Considerations for individualized first-line systemic treatment in advanced hepatocellular carcinoma. Curr Opin Pharmacol. 2023;70: 102365.
2. Rumgay H, Arnold M, Ferlay J, Lesi O, Cabasag CJ, Vignat J, et al. Global burden of primary liver cancer in 2020 and predictions to 2040. J Hepatol [Internet]. 2022 [cited 2023 Jul 19];77:1598–606. Available from: http://www.journal-of-hepatology.eu/article/S0168827822030227/fulltext.
3. Liver cancer survival rates | Cancer of the liver survival rates | American Cancer Society [Internet]. [cited 2023 Jul 19]. Available from: https://www.cancer.org/cancer/types/liver-cancer/detection-diagnosis-staging/survival-rates.html.
4. Suresh D, Srinivas AN, Prashant A, Harikumar KB, Kumar DP. Therapeutic options in hepatocellular carcinoma: a comprehensive review. Clin Exp Med. 2023
5. Ikeda M, Morizane C, Ueno M, Okusaka T, Ishii H, Furuse J. Chemotherapy for hepatocellular carcinoma: current status and future perspectives. Jpn J Clin Oncol. 2018;48:103–14.